Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Genome-wide association study of therapeutic opioid dosing identifies a novel locus upstream of OPRM1
Andrew H. Smith, Kevin P. Jensen, Jason Li, et al.
Molecular Psychiatry (2017) Vol. 22, Iss. 3, pp. 346-352
Open Access | Times Cited: 90

Showing 1-25 of 90 citing articles:

Opioid receptors: drivers to addiction?
Emmanuel Darcq, Brigitte L. Kieffer
Nature reviews. Neuroscience (2018) Vol. 19, Iss. 8, pp. 499-514
Closed Access | Times Cited: 304
Big Data’s Role in Precision Public Health
Shawn Dolley
Frontiers in Public Health (2018) Vol. 6
Open Access | Times Cited: 179
Association of OPRM1 Functional Coding Variant With Opioid Use Disorder
Hang Zhou, Christopher T. Rentsch, Zhongshan Cheng, et al.
JAMA Psychiatry (2020) Vol. 77, Iss. 10, pp. 1072-1072
Open Access | Times Cited: 165
High-Diversity Mouse Populations for Complex Traits
Michael C. Saul, Vivek M. Philip, Laura G. Reinholdt, et al.
Trends in Genetics (2019) Vol. 35, Iss. 7, pp. 501-514
Open Access | Times Cited: 150
Human Genetics of Addiction: New Insights and Future Directions
Dana B. Hancock, Christina A. Markunas, Laura J. Bierut, et al.
Current Psychiatry Reports (2018) Vol. 20, Iss. 2
Open Access | Times Cited: 139
Genetic–epigenetic interactions in cis: a major focus in the post-GWAS era
Catherine Do, Alyssa Shearer, Masako Suzuki, et al.
Genome biology (2017) Vol. 18, Iss. 1
Open Access | Times Cited: 126
Genetics of substance use disorders in the era of big data
Joel Gelernter, Renato Polimanti
Nature Reviews Genetics (2021) Vol. 22, Iss. 11, pp. 712-729
Open Access | Times Cited: 95
The Opioid Crisis and the Future of Addiction and Pain Therapeutics
Nathan P. Coussens, G. Sitta Sittampalam, Samantha G. Jonson, et al.
Journal of Pharmacology and Experimental Therapeutics (2019) Vol. 371, Iss. 2, pp. 396-408
Open Access | Times Cited: 89
Multi-trait genome-wide association study of opioid addiction: OPRM1 and beyond
Nathan Gaddis, Ravi Mathur, Jesse A. Marks, et al.
Scientific Reports (2022) Vol. 12, Iss. 1
Open Access | Times Cited: 52
Genome-wide Association Study Identifies a Regulatory Variant of RGMA Associated With Opioid Dependence in European Americans
Zhongshan Cheng, Hang Zhou, Richard Sherva, et al.
Biological Psychiatry (2018) Vol. 84, Iss. 10, pp. 762-770
Open Access | Times Cited: 77
A brief review of the genetics and pharmacogenetics of opioid use disorders
Wade H. Berrettini
Dialogues in Clinical Neuroscience (2017) Vol. 19, Iss. 3, pp. 229-236
Open Access | Times Cited: 70
Risk Factors and Prevention Strategies for Postoperative Opioid Abuse
Shuai Zhao, Fan Chen, Anqi Feng, et al.
Pain Research and Management (2019) Vol. 2019, pp. 1-12
Open Access | Times Cited: 61
Genetics of substance use disorders: a review
Joseph D. Deak, Emma C. Johnson
Psychological Medicine (2021) Vol. 51, Iss. 13, pp. 2189-2200
Open Access | Times Cited: 49
Genome-wide association study of problematic opioid prescription use in 132,113 23andMe research participants of European ancestry
Sandra Sanchez‐Roige, Pierre Fontanillas, Mariela Jennings, et al.
Molecular Psychiatry (2021) Vol. 26, Iss. 11, pp. 6209-6217
Open Access | Times Cited: 48
IUPHAR Review: New strategies for medications to treat substance use disorders
Iván D. Montoya, Nora D. Volkow
Pharmacological Research (2024) Vol. 200, pp. 107078-107078
Open Access | Times Cited: 7
Effect of short-term prescription opioids on DNA methylation of the OPRM1 promoter
José Vladimir Sandoval-Sierra, Francisco I. Salgado García, Jeffrey H. Brooks, et al.
Clinical Epigenetics (2020) Vol. 12, Iss. 1
Open Access | Times Cited: 40
Genome-Wide Correlation of DNA Methylation and Gene Expression in Postmortem Brain Tissues of Opioid Use Disorder Patients
Andi Liu, Yulin Dai, Emily Méndez, et al.
The International Journal of Neuropsychopharmacology (2021) Vol. 24, Iss. 11, pp. 879-891
Open Access | Times Cited: 34
The genetics and epigenetics of Neonatal Abstinence Syndrome
Elisha M. Wachman, Lindsay A. Farrer
Seminars in Fetal and Neonatal Medicine (2019) Vol. 24, Iss. 2, pp. 105-110
Closed Access | Times Cited: 41
<p><em>OPRM1</em> A118G Polymorphisms and Its Role in Opioid Addiction: Implication on Severity and Treatment Approaches</p>
Malik Mumtaz Taqi, Muhammad Faisal, Hadar Zaman
Pharmacogenomics and Personalized Medicine (2019) Vol. Volume 12, pp. 361-368
Open Access | Times Cited: 39
Pharmacogenetics of Opioid Use Disorder Treatment
Richard C. Crist, Toni‐Kim Clarke, Wade H. Berrettini
CNS Drugs (2018) Vol. 32, Iss. 4, pp. 305-320
Open Access | Times Cited: 38
Genetic variation regulates opioid-induced respiratory depression in mice
Jason A. Bubier, Hao He, Vivek M. Philip, et al.
Scientific Reports (2020) Vol. 10, Iss. 1
Open Access | Times Cited: 33
What place for prolonged-release buprenorphine depot-formulation Buvidal® in the treatment arsenal of opioid dependence? Insights from the French experience on buprenorphine
Florence Vorspan, Peter Hjelmström, Nicolas Simon, et al.
Expert Opinion on Drug Delivery (2019) Vol. 16, Iss. 9, pp. 907-914
Open Access | Times Cited: 33
Genetics and Opioids: Towards More Appropriate Prescription in Cancer Pain
Dario Bugada, Ferdinando Luca Lorini, Roberto Fumagalli, et al.
Cancers (2020) Vol. 12, Iss. 7, pp. 1951-1951
Open Access | Times Cited: 28
The Cholinergic System as a Treatment Target for Opioid Use Disorder
Kevin P. Jensen, Elise E. DeVito, Sarah W. Yip, et al.
CNS Drugs (2018) Vol. 32, Iss. 11, pp. 981-996
Open Access | Times Cited: 28
OPRM1, OPRK1, and COMT genetic polymorphisms associated with opioid effects on experimental pain: a randomized, double-blind, placebo-controlled study
Kwo Wei David Ho, Margaret R. Wallace, Roland Staud, et al.
The Pharmacogenomics Journal (2019) Vol. 20, Iss. 3, pp. 471-481
Open Access | Times Cited: 26
Page 1 - Next Page

Scroll to top